CN Patent

CN114062554B — 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法

Assigned to Shandong Bestcomm Pharmaceutical Co ltd · Expires 2023-07-21 · 3y expired

What this patent protects

本发明提供了一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法，该方法操作简便，专属性良好，且溶液稳定、灵敏度高、方法耐用性好，可用于对乙酰氨基酚布洛芬片的质量控制。

USPTO Abstract

本发明提供了一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法，该方法操作简便，专属性良好，且溶液稳定、灵敏度高、方法耐用性好，可用于对乙酰氨基酚布洛芬片的质量控制。

Drugs covered by this patent

Patent Metadata

Patent number
CN114062554B
Jurisdiction
CN
Classification
—
Expires
2023-07-21
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Bestcomm Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.